Clinical Trials Directory

Trials / Unknown

UnknownNCT02934906

Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women

A Multi-center Prospective Cohort Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women

Status
Unknown
Phase
Study type
Observational
Enrollment
55,497 (estimated)
Sponsor
Xinqiao Hospital of Chongqing · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This clinical study aims to investigate the anti-HPA antibodies caused neonatal alloimmune thrombocytopenia in Chinese pregnant women. The survey and data collect will help form an appropriate clinical screening procedure

Conditions

Interventions

TypeNameDescription
PROCEDUREStandard clinical treatment, including intravenous immunoglobulin and/or platelet transfusionObservational study.

Timeline

Start date
2017-01-01
Primary completion
2019-12-01
First posted
2016-10-17
Last updated
2016-10-17

Source: ClinicalTrials.gov record NCT02934906. Inclusion in this directory is not an endorsement.